SCHEMBL8987239

SCHEMBL8987239

CCOC(=O)CCCCCSc1ncc(-c2ccccc2)c(-c2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.48
PTGDR2 Q9Y5Y4 3/20 0.48
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PTGS2 P35354 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PTGES O14684 1/20 0.42
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8987043 1.00 FAAH (0.48) FAAHPTGDR2POLBKDM4ESMN1; SMN2
SCHEMBL8987067 1.00 FAAH (0.48) FAAHPTGDR2POLBKDM4ESMN1; SMN2
SCHEMBL8987281 0.85 PTGIR (0.50) ALDH1A1PTGS2PTGES
SCHEMBL8987417 0.85 PTGIR (0.50) ALDH1A1PTGS2PTGES
SCHEMBL8987348 0.82 PTGES (0.45) PTGES
SCHEMBL8987198 0.81 FAAH (0.51) FAAHSMN1; SMN2ALDH1A1MAPK1TDP1
SCHEMBL8987398 0.78 LTB4R (0.47) PTGES
SCHEMBL3282641 0.76 PTGES (0.41) PTGES
SCHEMBL3282637 0.76 PTGES (0.41) PTGES
Bicarbonate SCHEMBL3919502 0.76 PTGES (0.41) ALDH1A1PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed